ClinicalTrials.gg
Enrolling by invitationNCT07736859Sat-HyFoSyUpdated Jul 30, 2026

Satisfaction of Hysterosalpingo-Foam Sonography

An observational study in Infertility, sponsored by Central Hospital, Nancy, France. Enrolling by invitation at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Central Hospital, Nancy, France · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
Female
01

Study summary

To evaluate patient satisfaction following a HyFoSy examination performed as part of a fertility workup, by assessing the procedure's tolerability through a questionnaire administered immediately after the examination.

Read the detailed description

Tubal patency testing is an essential component of the fertility work-up. Worldwide, infertility currently affects 5-15% of couples. Tubal occlusion is one of the leading causes of female infertility, accounting for approximately 26% of cases.

Assessment of tubal patency is crucial for diagnosing tubal obstruction before initiating fertility treatment, including intrauterine insemination (IUI) or in vitro fertilization (IVF). It is also important for documenting the success of tubal recanalization following tubal reconstructive surgery. Furthermore, tubal patency assessment plays a key role in fertility counseling for women.

Laparoscopy with chromopertubation has long been considered the gold standard for evaluating tubal patency; however, its main limitation is its invasive nature. Hysterosalpingography (HSG) was the first non-surgical alternative developed for tubal patency testing. Potential adverse effects include infection, allergic reactions to iodinated contrast media, vasovagal reactions related to procedural pain, and uterine or cervical perforation. In addition, HSG exposes patients to ionizing radiation, with an estimated dose of approximately 5 mGy per examination.

HyFoSy can therefore be incorporated into the routine fertility assessment following a pelvic ultrasound examination. Patients are placed in the Trendelenburg position, after which a pelvic examination is performed to insert the catheter and inject the contrast medium. This allows simultaneous evaluation of the uterine cavity, tubal patency, and ovaries during a single, radiation-free procedure.

In this prospective study, the investigators aim to expand upon these findings by investigating several aspects of the patient experience that remain poorly described in the literature, including :

  • the quality of information provided before the examination
  • patients' overall experience and pre-procedural anxiety
  • the specific stages of the procedure associated with pain
  • the relationships between patients' experiences, their individual characteristics, and their healthcare pathways
02

Conditions studied

  • Infertility

Keywords

  • Infertility
  • HyFoSy
  • Satisfaction
03

In context

Infertility

2,085 studies on the registry are indexed under Infertility; 357 are open to participants now.

This study's planned enrollment of 200 is close to the median of 200 across 592 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 798 studies on the registry; 186 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women attending the fertility medicine unit who underwent a HyFoSy ultrasound examination.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provided verbal after receiving full information about the study procedures
  • Women
  • Aged 18 years or older
  • Attending the fertility medicine unit and undergoing a HyFoSy ultrasound examination
  • Affiliated with, or covered by, a social security health insurance scheme

Exclusion criteria

Exclusion Criteria :

  • Pregnant women
  • Women who are breastfeeding or in the postpartum period
  • Non-emancipated minors
  • Adults under legal protection (guardianship, curatorship, or judicial protection)
  • Adults unable to provide
  • Individuals deprived of liberty by judicial or administrative decision
  • Individuals receiving involuntary psychiatric care
  • Individuals who have declined participation in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Satisfaction level

    To evaluate patient satisfaction following a HyFoSy examination performed as part of an infertility workup by assessing the procedure's tolerability using a questionnaire administered immediately after the examination. Participants will be asked to rate their overall satisfaction on a scale from 0 to 10, with 10 indicating the highest level of satisfaction.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

Secondary outcomes

  1. Proportion of patients who received the information sheet and their satisfaction score with the information provided.

    To evaluate the quality and clarity of the information provided before the examination by assessing receipt of the information sheet, its comprehensibility, perceived usefulness, suggestions for improvement, and the use of additional sources of information.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

  2. Distribution of pre-examination anxiety levels.

    To assess apprehension related to the procedure by analyzing pre-examination anxiety levels. Participants will be asked to rate their level of anxiety before the examination as : very relaxed ; relaxed ; neutral ; anxious ; very anxious.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

  3. Proportion of painful experiences at each step of the procedure, and mean pain intensity during and after the examination (numerical rating scales).

    To identify the stage(s) of the procedure associated with pain by collecting patient-reported experience at each step (initial ultrasound, speculum insertion, catheter placement, contrast medium injection, post-injection ultrasound), as well as pain intensity during and after the examination using numerical rating scales.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

  4. Correlation between overall satisfaction score and patient characteristics and care pathways (sociodemographic data, gynecological and obstetric history, and medical and surgical history).

    To assess associations between patients' experience of the procedure and their characteristics and care pathways.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

  5. Correlation between overall satisfaction score and pain intensity.

    To analyze the relationship between pain and overall satisfaction.

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

  6. Comparison between anticipated experience of the examination and actual overall experience.

    Comparaison between anticipated experience (participants will be asked to indicate how they expected the examination to be, choosing one of the following options : not painful ; unpleasant ; painful ; very painful) and actual overall experience (participants will be asked to rate their overall experience of the examination as : excellent ; good ; fair ; unsatisfactory ; very unsatisfactory).

    Time frame: 30 minutes per participant (including time to provide study information and complete the questionnaire)

07

Study locations

1 site
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07736859
Responsible party
Mikael AGOPIANTZ (PU-PH - ART Center coordinator, Central Hospital, Nancy, France) — Principal investigator
First posted
Jul 30, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Sep 2027 (estimated)
Last update
Jul 30, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion